These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 30542731)

  • 41. Growth arrest DNA damage-inducible gene 45 gamma expression as a prognostic and predictive biomarker in hepatocellular carcinoma.
    Ou DL; Shyue SK; Lin LI; Feng ZR; Liou JY; Fan HH; Lee BS; Hsu C; Cheng AL
    Oncotarget; 2015 Sep; 6(29):27953-65. PubMed ID: 26172295
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Silencing of CDCA5 inhibits cancer progression and serves as a prognostic biomarker for hepatocellular carcinoma.
    Wang J; Xia C; Pu M; Dai B; Yang X; Shang R; Yang Z; Zhang R; Tao K; Dou K
    Oncol Rep; 2018 Oct; 40(4):1875-1884. PubMed ID: 30015982
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long noncoding RNA RUSC1-AS-N indicates poor prognosis and increases cell viability in hepatocellular carcinoma.
    Tang R; Wu JC; Zheng LM; Li ZR; Zhou KL; Zhang ZS; Xu DF; Chen C
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):388-396. PubMed ID: 29424895
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased expression of hematological and neurological expressed 1 (HN1) is associated with a poor prognosis of hepatocellular carcinoma and its knockdown inhibits cell growth and migration partly by down-regulation of c-Met.
    Chen JJ; Sun X; Mao QQ; Jiang XY; Zhao XG; Xu WJ; Zhong L
    Kaohsiung J Med Sci; 2020 Mar; 36(3):196-205. PubMed ID: 31749294
    [TBL] [Abstract][Full Text] [Related]  

  • 45. microRNA-520f inhibits hepatocellular carcinoma cell proliferation and invasion by targeting TM4SF1.
    Du X; Fan W; Chen Y
    Gene; 2018 May; 657():30-38. PubMed ID: 29505836
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ku80 functions as a tumor suppressor in hepatocellular carcinoma by inducing S-phase arrest through a p53-dependent pathway.
    Wei S; Xiong M; Zhan DQ; Liang BY; Wang YY; Gutmann DH; Huang ZY; Chen XP
    Carcinogenesis; 2012 Mar; 33(3):538-47. PubMed ID: 22226916
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Overexpression of RAB34 correlates with poor prognosis and tumor progression in hepatocellular carcinoma.
    Wu J; Lu Y; Qin A; Qiao Z; Jiang X
    Oncol Rep; 2017 Nov; 38(5):2967-2974. PubMed ID: 29048615
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma.
    Zhan DQ; Wei S; Liu C; Liang BY; Ji GB; Chen XP; Xiong M; Huang ZY
    J Gastroenterol Hepatol; 2012 Jan; 27(1):173-80. PubMed ID: 21777276
    [TBL] [Abstract][Full Text] [Related]  

  • 49. TRIM59 promotes tumor growth in hepatocellular carcinoma and regulates the cell cycle by degradation of protein phosphatase 1B.
    Ying H; Ji L; Xu Z; Fan X; Tong Y; Liu H; Zhao J; Cai X
    Cancer Lett; 2020 Mar; 473():13-24. PubMed ID: 31875525
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TRIP13 impairs mitotic checkpoint surveillance and is associated with poor prognosis in multiple myeloma.
    Tao Y; Yang G; Yang H; Song D; Hu L; Xie B; Wang H; Gao L; Gao M; Xu H; Xu Z; Wu X; Zhang Y; Zhu W; Zhan F; Shi J
    Oncotarget; 2017 Apr; 8(16):26718-26731. PubMed ID: 28157697
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
    Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
    BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HUS1 checkpoint clamp component (HUS1) is a potential tumor suppressor in primary hepatocellular carcinoma.
    Zhou ZQ; Zhao JJ; Chen CL; Liu Y; Zeng JX; Wu ZR; Tang Y; Zhu Q; Weng DS; Xia JC
    Mol Carcinog; 2019 Jan; 58(1):76-87. PubMed ID: 30182378
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Calreticulin down-regulation inhibits the cell growth, invasion and cell cycle progression of human hepatocellular carcinoma cells.
    Feng R; Ye J; Zhou C; Qi L; Fu Z; Yan B; Liang Z; Li R; Zhai W
    Diagn Pathol; 2015 Aug; 10():149. PubMed ID: 26307067
    [TBL] [Abstract][Full Text] [Related]  

  • 54. GABPA predicts prognosis and inhibits metastasis of hepatocellular carcinoma.
    Zhang S; Zhang K; Ji P; Zheng X; Jin J; Feng M; Liu P
    BMC Cancer; 2017 May; 17(1):380. PubMed ID: 28549418
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression and inhibitory role of TIMP-3 in hepatocellular carcinoma.
    Shen B; Jiang Y; Chen YR; Zheng HC; Zeng W; Li YY; Yin A; Nie Y
    Oncol Rep; 2016 Jul; 36(1):494-502. PubMed ID: 27222429
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vaccinia-related kinase 1 promotes hepatocellular carcinoma by controlling the levels of cell cycle regulators associated with G1/S transition.
    Lee N; Kwon JH; Kim YB; Kim SH; Park SJ; Xu W; Jung HY; Kim KT; Wang HJ; Choi KY
    Oncotarget; 2015 Oct; 6(30):30130-48. PubMed ID: 26375549
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Upregulated expression of CAP1 is associated with tumor migration and metastasis in hepatocellular carcinoma.
    Liu Y; Cui X; Hu B; Lu C; Huang X; Cai J; He S; Lv L; Cong X; Liu G; Zhang Y; Ni R
    Pathol Res Pract; 2014 Mar; 210(3):169-75. PubMed ID: 24359721
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cyclin B2 Overexpression in Human Hepatocellular Carcinoma is Associated with Poor Prognosis.
    Li R; Jiang X; Zhang Y; Wang S; Chen X; Yu X; Ma J; Huang X
    Arch Med Res; 2019 Jan; 50(1):10-17. PubMed ID: 31101236
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sp2 promotes invasion and metastasis of hepatocellular carcinoma by targeting TRIB3 protein.
    Zhu Y; Cui J; Liu J; Hua W; Wei W; Sun G
    Cancer Med; 2020 May; 9(10):3592-3603. PubMed ID: 32160655
    [TBL] [Abstract][Full Text] [Related]  

  • 60. KLHL21, a novel gene that contributes to the progression of hepatocellular carcinoma.
    Shi L; Zhang W; Zou F; Mei L; Wu G; Teng Y
    BMC Cancer; 2016 Oct; 16(1):815. PubMed ID: 27769251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.